Egyptian Retina Journal

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 5  |  Issue : 2  |  Page : 32--34

Role of retrobulbar dexamethasone in the treatment of optic neuritis


Sourav Kumar Bose, Gitanjali Bose 
 Nayan Jyoti Eye Care Centre, Kolkata, West Bengal, India

Correspondence Address:
Dr. Sourav Kumar Bose
Nayan Jyoti Eye Care Centre, 9, Jessore Road, Kazipara, Kolkata - 700 028, West Bengal
India

Optic neuritis is a disease entity characterized by, as the name clearly suggests, inflammation of the optic nerve. Over many years, the treatment of optic neuritis has been the use of steroids. The Optic Neuritis Treatment Trial laid the foundation stone for calibrating the use of steroids. However, all modalities have their own adverse effects, in terms of cost, patient compliance, adverse effects, etc. The purpose of this article is to evaluate the role of retrobulbar dexamethasone in the treatment of optic neuritis. After proper patient preparation, a neuritic cocktail of dexamethasone and lignocaine, in pretitrated amounts, is injected in the retrobulbar space. This was administered 3 times at an interval of 48 h, followed by oral prednisolone and supplemented with oral Vitamin B complex. Of 14 patients, 8 (57.1%) patients gained to a best-corrected visual acuity (BCVA) of 6/12 or more, 4 (28.5%) patients had BCVA between 6/24 and 6/18, and 2 (14.2%) patients had BCVA of 6/60. Hence, we conclude that such affordable drug combination can provide a cost-effective measure to treat optic neuritis.


How to cite this article:
Bose SK, Bose G. Role of retrobulbar dexamethasone in the treatment of optic neuritis.Egypt Retina J 2018;5:32-34


How to cite this URL:
Bose SK, Bose G. Role of retrobulbar dexamethasone in the treatment of optic neuritis. Egypt Retina J [serial online] 2018 [cited 2019 Mar 22 ];5:32-34
Available from: http://www.egyptretinaj.com/article.asp?issn=2347-5617;year=2018;volume=5;issue=2;spage=32;epage=34;aulast=Bose;type=0